| 儿童退热药风险干预研究 |
| |
| 引用本文： | 张昊,赵频,武志昂.儿童退热药风险干预研究[J].中国药物警戒,2012,9(4):218-221. |
| |
| 作者姓名： | 张昊 赵频 武志昂 |
| |
| 作者单位： | 沈阳药科大学工商管理学院,辽宁沈阳,110016 |
| |
| 摘 要： | 介绍了我国儿童退热药的种类、使用情况及其不良反应,并对儿童用药的风险来源进行分析.经查阅美国食品药品监督局及欧洲药品评价局等官方网站,得出欧美等国关于儿童药物的注册方案及不良反应的干预措施.最后提出降低小儿退热药用药风险的相关建议,以促进我国小儿退热药的安全使用.
|
| 关 键 词： | 儿童退热药 风险来源 干预措施 |
A Research on the Risk of Intervention in Antipyretics for Children |
| |
| ZHANG Hao
,
ZHAO Pin
,
WU Zhi-ang.A Research on the Risk of Intervention in Antipyretics for Children[J].Chinese JOurnal of Pharmacovigilance,2012,9(4):218-221. |
| |
| Authors: | ZHANG Hao ZHAO Pin WU Zhi-ang |
| |
| Institution: | (College of Business Administration, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China) |
| |
| Abstract: | This paper describes the varieties, usage situations and adverse reactions of Antipyretics for children and analyses the sources of risk of the drugs for children. The registration schemes and interventions in the adverse reactions of drugs for children in USA and Europe have been concluded by scanning the official websites of FDA and EMEA. At the end of the paper, the advice related with the risk of antipyretic for children are brought up to contribute to safe use of antipyretics for children in China. |
| |
| Keywords: | antipyretics for children sources of risk intervention |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
